Hitendra S. Solanki

20 posts

Hitendra S. Solanki

@Hitendras08

Tampa Katılım Mayıs 2014

46 Takip Edilen41 Takipçiler

Hitendra S. Solanki@Hitendras08·31 Eki

#HauraLab Published in Cancer Research @CR_AACR. Targeting CDK12/13 offers a promising new strategy to overcome or prevent resistance to KRAS inhibitors. @MoffittNews #KRASG12C #AACR #LungCancer @MoffittResearch doi.org/10.1158/0008-5… aacrjournals.org/cancerres/arti…

English

Hitendra S. Solanki@Hitendras08·31 Eki

#HauraLab Published with $RVMD Revolution Medicines: KRAS G12C resistance overcome by RAS(ON) multi-selective inhibitor. @MoffittNews #KRASG12C #AACR @AndriyMarusyk @Binadesai14 #KRASG12C #LungCancer aacrjournals.org/cancerres/arti…

English

Hitendra S. Solanki retweetledi

Dr. Bina Desai@Binadesai14·30 Eki

📢 Publication alert 📢 In collaboration with friend and colleague @Hitendras08 from #Hauralab we show diverse resistance mechanisms of #KRASG12C inhibitors and strategies to overcome #therapyresistance #Sotorasib #adagrasib #RMC7977 #RMC4998 👇👇👇 aacrjournals.org/cancerres/arti…

Bruna Pellini, MD@BrunaPellini

🚨New from #HauraLab @Hitendras08 @MoffittNews : In #KRASG12C NSCLC models, resistance to KRAS G12C (OFF) inhibitors can be overcome by RAS-GTP (ON) inhibition highlighting news strategies to counter adaptive RAS signaling 🔬💥 see full paper below: 👇🏼👇🏼👇🏼👇🏼👇🏼 @AACR aacrjournals.org/cancerres/onli… @AndriyMarusyk @Binadesai14

English

202

Hitendra S. Solanki retweetledi

Moffitt Cancer Center@MoffittNews·30 Eki

x.com/i/article/1983…

ZXX

495

Hitendra S. Solanki retweetledi

Bruna Pellini, MD@BrunaPellini·30 Eki

English

2.4K

Hitendra S. Solanki@Hitendras08·29 Nis

Join me on Poster Number: 5512 Combining RAS(ON) G12C-selective and RAS(ON) multi-selective inhibitors overcomes sotorasib resistance driven byKRASG12C amplification or NRASG13R mutation #AACR2025 #MoffittAACR25 @MoffittNews

English

178

Hitendra S. Solanki@Hitendras08·7 Şub

A game-changer for treating KRAS G12C-mutant #NSCLC Protein Interaction Assay May Identify Best #NSCLC Candidates for #KRAS G12C Inhibitors #Hauralab @MoffittNews @MoffittResearch #PrecisionMedicine insideprecisionmedicine.com/topics/oncolog…

English

Hitendra S. Solanki@Hitendras08·7 Şub

Our new publication from the Eric Haura lab (#Hauralab) highlights the importance of in situ RAS-RAF interactions as a potential predictive biomarker for identifying #NSCLC patients most likely to benefit from #KRASG12Ci @MoffittNews @MoffittResearch doi.org/10.1158/1078-0…

English

273

Hitendra S. Solanki retweetledi

Bruna Pellini, MD@BrunaPellini·24 Ara

🚨This work would not have been possible without @hilalozakinci @Binadesai14 and @AndriyMarusyk. True team science project at @MoffittNews. Tweetorial to follow soon!

OncoDaily@oncodaily

Preclinical data on potential combination to overcome KRASi resistance - @Aiims1742 @BrunaPellini @MoffittNews oncodaily.com/url/210842 #Cancer #LCSM #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

English

1.8K

Hitendra S. Solanki@Hitendras08·9 Nis

#MoffittAACR24 @NewsMoffitt @MoffittNews #HauraLab

QME

1.9K

Hitendra S. Solanki retweetledi

Bruna Pellini, MD@BrunaPellini·8 Şub

📣#HauraLab Retreat gathering after a day discussing all of our projects in #KRAS mutant #NSCLC 🔬🧑🏾‍🔬👩🏼‍🔬stay tuned for some cool work that we are doing this year 🚨 Glad to work with ✨⭐️ that teach me something new day every day @Hitendras08 @TheYCluster @biodataguy @hilalozakinci @MoffittNews @MoffittResearch

Tampa, FL 🇺🇸 English

2.4K

Hitendra S. Solanki@Hitendras08·13 Eki

B084: Sotorasib/SHP2 inhibitors combo, KRASG12C(ON)I and RASMULT (ON)I effectively target KRASG12C tumors developing secondary resistance to Sotorasib via KRASG12C amplification. Poster @aacr -nci-eortc @Rev_Medicine @MoffittNews

English

144

Hitendra S. Solanki@Hitendras08·22 Kas

@DHLUSHelp I have sent dm, Please respond

English

DHL U.S. Help@DHLUSHelp·22 Kas

@Hitendras08 For help and to keep your info private, please DM/Private Message the details along with, your name, delivery address and 10 digit tracking number. ^MS

English

Hitendra S. Solanki@Hitendras08·22 Kas

@DHLUS My package (JD014600010444091208) is on hold in Germany. Can you please update on this. Tracking Code: 5343621942

English

Hitendra S. Solanki retweetledi

Moffitt Cancer Center@MoffittNews·23 Haz

Today at 10:05 a.m. in #AACR20 mini-symposium, Dr. Hitendra Singh Solanki shares data on adaptive signaling mechanisms enabling cell to survive KRASG12C inhibition & how it could help identify new therapies for lung cancer patients. View abstract: bit.ly/2CpTKP5